Alpha 2.0
Login Register
» Journals » Lancet Reg Health Southeast Asia

The Lancet Regional Health. Southeast Asia

The Lancet Regional Health. Southeast Asia is a scientific journal, published since 2022 in English. The journal's country of origin is United Kingdom.
Details
Abbr. Lancet Reg Health Southeast Asia
Start 2022
End Continuing
Frequency Monthly
e-ISSN 2772-3682
Country United Kingdom
Language English
Metrics
h-index / Ranks: 14576 9
SJR / Ranks: 3059 1140
CiteScore / Ranks: 12928 1.00
Recent Articles
1.
A population-representative serosurvey estimating vaccine-induced immunity against measles, rubella, hepatitis B and severe acute respiratory syndrome coronavirus 2 in Timor-Leste
Arkell P, Tanesi M, Martins N, Gomes N, Oakley T, Solano V, et al.
Lancet Reg Health Southeast Asia . 2025 Mar; 34:100525. PMID: 40084157
Background: Serosurveillance can be used to assess population immunity to vaccine-preventable diseases (VPDs). This study aimed to determine seroprevalence of four VPDs across Timor-Leste and identify immunity gaps. Methods: A...
2.
Insights from ESMO Asia Congress 2024
Apoorv T
Lancet Reg Health Southeast Asia . 2025 Mar; 34:100554. PMID: 40084156
No abstract available.
3.
Challenges associated with dapsone for leprosy treatment in Indonesia - urgent need for access to alternative antimicrobial drugs
Krismawati H, Harianja M, Oktavian A, Bogh C, Ataupah M, Laiskodat R, et al.
Lancet Reg Health Southeast Asia . 2025 Mar; 34:100555. PMID: 40084155
Leprosy is effectively treated with multi-drug therapy (MDT), a regimen containing three antibiotic drugs, including dapsone - a sulfone drug associated with potentially life-threatening adverse drug reactions. Specifically, dapsone hypersensitivity...
4.
Minimum service standards assessment tool and the hospital strengthening program: a novel first step towards the quality improvement of Nepal's national hospital system
Pokhrel R, Knoble A, Gautam P, Shah M, Paudel P, Amatya A, et al.
Lancet Reg Health Southeast Asia . 2025 Mar; 34:100548. PMID: 40084154
Funding: No external funding.
5.
Community mobilisation and incentivisation as a pathway to sustainable TB control
Ali I
Lancet Reg Health Southeast Asia . 2025 Mar; 34:100551. PMID: 40070554
No abstract available.
6.
The burden of atrial fibrillation and unmet needs of its management in Southeast Asia and South Asia
Krittayaphong R, Kaolawanich Y, Phrommintikul A, Guruparan M, Subaschandran K, Bahuleyan C, et al.
Lancet Reg Health Southeast Asia . 2025 Mar; 34:100549. PMID: 40070553
No abstract available.
7.
Unveiling the cancer epidemic in India: a glimpse into GLOBOCAN 2022 and past patterns
Singh K, Grover A, Dhanasekaran K
Lancet Reg Health Southeast Asia . 2025 Mar; 34:100546. PMID: 40070552
Background: The Global Cancer Observatory (GLOBOCAN) 2022 estimates highlight cancer as a significant global health problem. In the South-East Asia-region, India ranks third in terms of cancer incidence, second for...
8.
Language as a catalyst for success: a blueprint for standardized terminology and multilingual health literacy in Pakistan
Irfan H, Farooq A, Toseef M
Lancet Reg Health Southeast Asia . 2025 Mar; 34:100544. PMID: 40034833
No abstract available.
9.
Trends in female breast cancer among adolescent and young adults in Southeast Asia
Chen J, Ho F, Feliciano E, Wu J, Magsanoc-Alikpala K, Dee E
Lancet Reg Health Southeast Asia . 2025 Mar; 34:100545. PMID: 40034832
No abstract available.
10.
Corrigendum to "Access to timely cancer treatment initiation in India: extent, determinants and trends" [The Lancet Regional Health - Southeast Asia, Volume 32, January 2025, 100514]
Halder P, Dixit J, Gupta N, Mehra N, Singh A, Malhotra P, et al.
Lancet Reg Health Southeast Asia . 2025 Mar; 34:100543. PMID: 40026837
[This corrects the article DOI: 10.1016/j.lansea.2024.100514.].